WST

West to Participate in Upcoming Investor Conference

Retrieved on: 
Tuesday, April 30, 2024
WST, Bank, Conference

EXTON, Pa., April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.

Key Points: 
  • EXTON, Pa., April 30, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Bank of America Securities Healthcare Conference in Las Vegas, NV on Tuesday, May 14, 2024, at 11:20 AM PT.
  • A live audio webcast of the event will be available in the "Investors" section of the Company's website at www.westpharma.com .
  • Replay of the webcasts will be available for approximately 90 days after the events.

West to Host First-Quarter 2024 Conference Call

Retrieved on: 
Thursday, April 11, 2024
Webcast, WST, Telephone, PIN

To participate in the conference call by asking questions to Management, please register in advance by clicking here .

Key Points: 
  • To participate in the conference call by asking questions to Management, please register in advance by clicking here .
  • Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that will be used to access the call.
  • Management will refer to a slide presentation during the call, which will be made available on the day of the call.
  • A replay of the conference call and webcast will be available on the Company's website for 30 days.

Williamson County Teen Organizes Stuffed Animal Drive for Abused Children in Recognition of Child Abuse Prevention Month

Retrieved on: 
Wednesday, April 10, 2024
Education, Stuff, Learning, Davis House, Animal, Toy Biz, Hope, Safety, Love, Life, County, Child, WST, Child abuse, Toy

FRANKLIN, Tenn., April 10, 2024 /PRNewswire-PRWeb/ -- Kenny Royer, a Williamson County high school junior, is on a mission to help abused children especially during this critical time of National Child Abuse Prevention Month in April. In collaboration with Davis House Child Advocacy Center, he's launched a Stuffed Animal Drive, aimed at helping provide a sense of security and comfort to vulnerable children.

Key Points: 
  • Williamson County teen is organizing a Stuffed Animal Drive with Davis House Child Advocacy Center to bring comfort to abused children.
  • FRANKLIN, Tenn., April 10, 2024 /PRNewswire-PRWeb/ -- Kenny Royer, a Williamson County high school junior, is on a mission to help abused children especially during this critical time of National Child Abuse Prevention Month in April.
  • In collaboration with Davis House Child Advocacy Center , he's launched a Stuffed Animal Drive, aimed at helping provide a sense of security and comfort to vulnerable children.
  • This tradition coincides perfectly with the spirit of Child Abuse Prevention Month, which focuses on creating a safe and supportive environment for all children.

West to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, February 28, 2024
Barclays, Conference, WST, Medtech

EXTON, Pa., Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET.

Key Points: 
  • EXTON, Pa., Feb. 28, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the Barclays 26th Annual Global Healthcare Conference in Miami, FL on Tuesday, March 12, 2024, at 1:05 PM ET.
  • It will also present at the KeyBanc Virtual Life Sciences & MedTech Investor Forum on Tuesday, March 19, 2024, at 9:00 AM ET.
  • A live audio webcast of each event will be available in the "Investors" section of the Company's website at www.westpharma.com .
  • Replay of the webcasts will be available for approximately 90 days after the events.

West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity

Retrieved on: 
Wednesday, February 7, 2024
Family, Environment, Organic, DEI, Risk, Culture, WST, Veteran, Workforce, Human, Woman, Nursing

EXTON, Pa., Feb. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it is recognized as one of America's Greatest Workplaces for Diversity 2024 by Newsweek and Plant-A Insights Group. This survey included interviews with over 220,000 individuals and analysis of more than 1.5 million company reviews collected in 2022 and 2023.

Key Points: 
  • EXTON, Pa., Feb. 7, 2024 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it is recognized as one of America's Greatest Workplaces for Diversity 2024 by Newsweek and Plant-A Insights Group.
  • Additionally, West offers Employee Business Resource Groups (EBRGs) in focus areas like multiculturalism, veterans and women's initiatives, with active chapters in regions where West operates.
  • Newsweek and market-data research firm Plant-A Insights are proud to introduce 'America's Greatest Workplaces for Diversity 2024,' highlighting companies that are committed to offering diverse and inclusive work environment," said Nancy Cooper, Global Editor-in-Chief, Newsweek.
  • For the complete Newsweek list of America's Greatest Workplaces for Diversity 2024, please visit https://www.newsweek.com/rankings/americas-greatest-workplaces-diversity... .

West to Host Fourth-Quarter and Full-Year 2023 Conference Call

Retrieved on: 
Thursday, February 1, 2024
Telephone, WST, Webcast, PIN

To participate in the conference call by asking questions to Management, please register in advance by clicking here .

Key Points: 
  • To participate in the conference call by asking questions to Management, please register in advance by clicking here .
  • Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that will be used to access the call.
  • Management will refer to a slide presentation during the call, which will be made available on the day of the call.
  • A replay of the conference call and webcast will be available on the Company's website for 30 days.

Sotera Health Appoints Karen Flynn to Board of Directors

Retrieved on: 
Monday, November 13, 2023
CTLT, WST, NYSE, Senior, Audit committee, Interim, University of Pennsylvania, West Pharmaceutical Services, Strategic planning, Compensation, Committee, Boston University, Catalent, Business administration, Biopharmaceutical, SHC, Compensated emancipation, University, Engineering, Management, Science

CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent director to its Board.

Key Points: 
  • CLEVELAND, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Karen Flynn as a new independent director to its Board.
  • Ms. Flynn is an accomplished healthcare leader with over 35 years of commercial, operations and general management experience in the pharmaceutical services industry.
  • “We are excited to welcome Karen to our Board of Directors,” said Michael B. Petras, Jr., Chairman and Chief Executive Officer of Sotera Health.
  • Additionally, her strong Board leadership and governance experience will be valuable as we advance as a public company.”
    Ms. Flynn currently serves on the Board of Directors of Quanterix Corporation (Nasdaq: QTRX), where she is a member of the Compensation and Nominating and Governance Committees and on the Board of Directors of Catalent.

Over 5,000 Shareholders and Clients Attend 30th Annual Baron Investment Conference

Retrieved on: 
Friday, November 10, 2023
Banking, Other Professional Services, Professional Services, Finance, Diamond, Baron, WST, Ronald S. Baron, KNSL, NYSE, Entrepreneurship, Beautiful Noise, FactSet, Choice Hotels, CNBC, CoStar Group, Squawk Box, Neil Diamond, Q&A, Capital, Friends, Metropolitan Opera House, Conference, FIGS, West Pharmaceutical Services, FDS, Management, Nightclub

Baron Capital held its 30th Annual Baron Investment Conference today at the Metropolitan Opera House at Lincoln Center in New York City.

Key Points: 
  • Baron Capital held its 30th Annual Baron Investment Conference today at the Metropolitan Opera House at Lincoln Center in New York City.
  • "It’s a privilege for us to host the Annual Baron Investment Conference, which gives us the opportunity to meet our clients and shareholders and introduce them to the leadership of companies in which we are invested,” said Ron Baron, Chairman, CEO, and Founder of Baron Capital.
  • Baron Capital also provides, at its own expense, entertainment in appreciation of the support of our clients and shareholders.
  • We look forward to seeing everyone back next year for the 31st Annual Baron Investment Conference."

West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device

Retrieved on: 
Monday, December 4, 2023
WST, West Pharmaceutical Services, Society, NYSE

EXTON, Pa., Dec. 4, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device.

Key Points: 
  • West expands administration systems portfolio with new smaller size needle-free admixture device for immediate use IV drug transfer designed to maximize the benefits of point-of-care nursing.
  • EXTON, Pa., Dec. 4, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced FDA 510(k) clearance and launch of its Vial2Bag Advanced® 13mm admixture device.
  • The addition of the Vial2Bag Advanced® 13mm admixture device complements West's existing Vial2Bag Advanced® 20mm admixture device, with the two products providing options for the reconstitution and transfer of a drug using either a 13mm or 20mm vial and an IV bag before administration to the patient.
  • Vial2Bag Advanced® 13mm admixture device has been officially launched at Progressive Medical Inc's Booth #500 at the American Society of Health-System Pharmacists Midyear Clinical Meeting Dec. 3 through 7, in Anaheim, CA.

West to Participate in Upcoming Investor Conferences

Retrieved on: 
Wednesday, November 1, 2023
WST, Conference, NYSE, West Pharmaceutical Services, Pharmaceutical industry

EXTON, Pa., Nov. 1, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at Jefferies Healthcare Conference in London, UK on Tuesday, November 14, 2023 at 10:00 AM GBT.

Key Points: 
  • EXTON, Pa., Nov. 1, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at Jefferies Healthcare Conference in London, UK on Tuesday, November 14, 2023 at 10:00 AM GBT.
  • It will also hold a fireside chat at the Stephens Annual Investment Conference in Nashville, TN on Thursday, November 16, 2023 at 8:00 AM CST.
  • A live audio webcast will be available in the "Investors" section of the Company's website at www.westpharma.com .
  • Replay of the webcasts will be available for approximately 90 days after the events.